With the cancer center’s corporate ties under scrutiny, the hospital told employees that no one should profit personally from representing MSK on outside boards.
from NYT > Technology https://ift.tt/2IpPvlz
from NYT > Technology https://ift.tt/2IpPvlz
Sloan Kettering Executive Turns Over Windfall Stake in Biotech Start-Up
![Sloan Kettering Executive Turns Over Windfall Stake in Biotech Start-Up]()
Reviewed by swadu
on
September 30, 2018
Rating:
No comments: